![Transparency Market Researchが調査・発行した産業分析レポートです。腎障害型シスチノーシスの世界市場2019-2027：治療種類別（療法（全身性枯渇療法、対症療法）、腎移植）、販売チャネル別 / Nephropathic Cystinosis Treatment Market (Treatment Type: Therapy [Systemic Depletion Therapy and Symptomatic Therapy] and Renal Transplantation; and Sales Channel: Hospitals, Specialty/Retail Pharmacies, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027 / TMR2006028資料のイメージです。](https://www.marketresearch.co.jp/images-folder2/report-contents-89.gif) | • レポートコード：TMR2006028 • 出版社/出版日：Transparency Market Research / 2020年3月 • レポート形態：英文、PDF、162ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、腎障害型シスチノーシスの世界市場について、序論、仮定・調査手法、エグゼクティブサマリー、市場動向、キーインサイト、治療種類別（療法（全身性枯渇療法、対症療法）、腎移植）分析、販売チャネル別分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東アフリカ）分析、競争状況などを総合的に調査・分析して掲載しております。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場動向 ・キーインサイト ・腎障害型シスチノーシスの世界市場規模：治療種類別（療法（全身性枯渇療法、対症療法）、腎移植） ・腎障害型シスチノーシスの世界市場規模：販売チャネル別 ・腎障害型シスチノーシスの世界市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東アフリカ） ・競争状況 |
Nephropathic Cystinosis Treatment Market – Scope of the Report
TMR’S report on the global nephropathic cystinosis treatment market studies past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the said market during the forecast period from 2019 to 2027. The report provides the overall market revenue of the global nephropathic cystinosis treatment market for the period of 2017–2027, with 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global nephropathic cystinosis treatment market for the forecast period.
The report has been prepared after an extensive primary and secondary research. Primary research involves bulk of research efforts, wherein, analysts carry out interviews with key opinion leaders, industry leaders, and opinion makers. Extensive secondary research involves referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global nephropathic cystinosis treatment market.
Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of top-down and bottom-up approach to study various phenomena in the global nephropathic cystinosis treatment market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Furthermore, the report sheds light on changing competitive dynamics in the global nephropathic cystinosis treatment market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global nephropathic cystinosis treatment market.
The report delves into the competitive landscape of the global nephropathic cystinosis treatment market. Key players operating in the global nephropathic cystinosis treatment market have been identified, and each one of them has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOTs are some of the attributes of players in the global nephropathic cystinosis treatment market that have been profiled in this report.
Key Questions Answered in Nephropathic Cystinosis Treatment Market Report
What is the sales/revenue generated by each treatment type and sales channel segment of the nephropathic cystinosis treatment market across all regions during the forecast period?
What are the opportunities in the global nephropathic cystinosis treatment market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which region is likely to expand at the fastest CAGR during the forecast period?
Which nephropathic cystinosis treatment type and sales channel segments are expected to generate the highest revenue globally in 2027? Which segment is projected to expand at the highest CAGR during the forecast period?
What is the market share or position of different companies operating in the global market in 2018?
Nephropathic Cystinosis Treatment Market – Research Objectives and Research Approach
The comprehensive report on the global nephropathic cystinosis treatment market begins with an overview of the said market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study, key industrial developments in terms of merger, acquisition, strategic partnerships, regulatory scenario, pipeline analysis, and disease epidemiology have been provided.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into small sections. The entire report comprises an exhaustive collection of graphs and tables appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global nephropathic cystinosis treatment market in terms of treatment type, sales channel, and region. Key segments under each criteria have been studied at length, and the market share for each of them at the end of 2027 has been provided herein. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global nephropathic cystinosis treatment market.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Nephropathic Cystinosis Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Treatment Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Nephropathic Cystinosis Treatment Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. 5.1.Regulatory Scenario by Region/globally
5.2. 5.2.Pipeline Analysis
5.3. 5.3.Nephropathic Cystinosis Epidemiology: Overview
6. Global Nephropathic Cystinosis Treatment Market Analysis and Forecast, by Treatment Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Treatment Type, 2017–2027
6.3.1. Therapy
6.3.1.1. Systemic Depletion Therapy
6.3.1.2. Symptomatic Therapy
6.3.2. Renal Transplantation
6.4. Market Attractiveness, by Treatment Type, 2019–2027
7. Global Nephropathic Cystinosis Treatment Market Analysis and Forecast, by Sales Channel
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Sales Channel, 2017–2027
7.3.1. Hospitals
7.3.2. Specialty/Retail Pharmacies
7.3.3. Others
7.4. Market Attractiveness, by Sales Channel, 2019–2027
8. Global Nephropathic Cystinosis Treatment Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness, by Region, 2019–2027
9. North America Nephropathic Cystinosis Treatment Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Treatment Type, 2017–2027
9.2.1. Therapy
9.2.1.1. Systemic Depletion Therapy
9.2.1.2. Symptomatic Therapy
9.2.2. Renal Transplantation
9.3. Market Value Forecast, by Sales Channel, 2017–2027
9.3.1. Hospitals
9.3.2. Specialty/Retail Pharmacies
9.3.3. Others
9.4. Market Value Forecast, by Country, 2017–2027
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis, 2019–2027
9.5.1. By Treatment Type
9.5.2. By Sales Channel
9.5.3. By Country
10. Europe Nephropathic Cystinosis Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Treatment Type, 2017–2027
10.2.1. Therapy
10.2.1.1. Systemic Depletion Therapy
10.2.1.2. Symptomatic Therapy
10.2.2. Renal Transplantation
10.3. Market Value Forecast, by Sales Channel, 2017–2027
10.3.1. Hospitals
10.3.2. Specialty/Retail Pharmacies
10.3.3. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017–2027
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis, 2019–2027
10.5.1. By Treatment Type
10.5.2. By Sales Channel
10.5.3. By Country/Sub-region
11. Asia Pacific Nephropathic Cystinosis Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Treatment Type, 2017–2027
11.2.1. Therapy
11.2.1.1. Systemic Depletion Therapy
11.2.1.2. Symptomatic Therapy
11.2.2. Renal Transplantation
11.3. Market Value Forecast, by Sales Channel, 2017–2027
11.3.1. Hospitals
11.3.2. Specialty/Retail Pharmacies
11.3.3. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017–2027
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis, 2019–2027
11.5.1. By Treatment Type
11.5.2. By Sales Channel
11.5.3. By Country/Sub-region
12. Latin America Nephropathic Cystinosis Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Treatment Type, 2017–2027
12.2.1. Therapy
12.2.1.1. Systemic Depletion Therapy
12.2.1.2. Symptomatic Therapy
12.2.2. Renal Transplantation
12.3. Market Value Forecast, by Sales Channel, 2017–2027
12.3.1. Hospitals
12.3.2. Specialty/Retail Pharmacies
12.3.3. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017–2027
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis, 2019–2027
12.5.1. By Treatment Type
12.5.2. By Sales Channel
12.5.3. By Country/Sub-region
13. Middle East & Africa Nephropathic Cystinosis Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Treatment Type, 2017–2027
13.2.1. Therapy
13.2.1.1. Systemic Depletion Therapy
13.2.1.2. Symptomatic Therapy
13.2.2. Renal Transplantation
13.3. Market Value Forecast, by Sales Channel, 2017–2027
13.3.1. Hospitals
13.3.2. Specialty/Retail Pharmacies
13.3.3. Others
13.4. Market Value Forecast, by Country/Sub-region, 2017–2027
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis, 2019–2027
13.5.1. By Treatment Type
13.5.2. By Sales Channel
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of companies)
14.2. Market Share/Position Analysis, by Company (2018)
14.3. Company Profiles
14.3.1. Horizon Therapeutics plc.
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Company Financials
14.3.1.3. Growth Strategies
14.3.1.4. SWOT Analysis
14.3.2. Mylan N.V.
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Company Financials
14.3.2.3. Growth Strategies
14.3.2.4. SWOT Analysis
14.3.3. Chiesi Farmaceutici SpA
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Company Financials
14.3.3.3. Growth Strategies
14.3.3.4. SWOT Analysis
14.3.4. Recordati Rare Diseases
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Company Financials
14.3.4.3. Growth Strategies
14.3.4.4. SWOT Analysis
14.3.5. AVROBIO, Inc.
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Company Financials
14.3.5.3. Growth Strategies
14.3.5.4. SWOT Analysis
14.3.6. Leadiant Biosciences, Inc.
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Company Financials
14.3.6.3. Growth Strategies
14.3.6.4. SWOT Analysis
14.3.7. Eloxx Pharmaceuticals
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Company Financials
14.3.7.3. Growth Strategies
14.3.7.4. SWOT Analysis
14.3.8. GlaxoSmithKline plc
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Company Financials
14.3.8.3. Growth Strategies
14.3.8.4. SWOT Analysis
List of TablesTable 01: Pipeline Analysis- Nephropathic Cystinosis
Table 02: Global Nephropathic Cystinosis Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027
Table 03: Global Nephropathic Cystinosis Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017–2027
Table 04: Global Nephropathic Cystinosis Treatment Market Value (US$ Mn) Forecast, by Sales Channel, 2017–2027
Table 05: Global Nephropathic Cystinosis Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 06: North America Nephropathic Cystinosis Treatment Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 07: North America Nephropathic Cystinosis Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027
Table 08: North America Nephropathic Cystinosis Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017–2027
Table 09: North America Nephropathic Cystinosis Treatment Market Value (US$ Mn) Forecast, by Sales Channel, 2017–2027
Table 10: Europe Nephropathic Cystinosis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 11: Europe Nephropathic Cystinosis Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027
Table 12: Europe Nephropathic Cystinosis Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017–2027
Table 13: Europe Nephropathic Cystinosis Treatment Market Value (US$ Mn) Forecast, by Sales Channel, 2017–2027
Table 14: Asia Pacific Nephropathic Cystinosis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 15: Asia Pacific Nephropathic Cystinosis Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027
Table 16: Asia Pacific Nephropathic Cystinosis Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017–2027
Table 17: Asia Pacific Nephropathic Cystinosis Treatment Market Value (US$ Mn) Forecast, by Sales Channel, 2017–2027
Table 18: Latin America Nephropathic Cystinosis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 19: Latin America Nephropathic Cystinosis Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027
Table 20: Latin America Nephropathic Cystinosis Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017–2027
Table 21: Latin America Nephropathic Cystinosis Treatment Market Value (US$ Mn) Forecast, by Sales Channel, 2017–2027
Table 22: Middle East & Africa Nephropathic Cystinosis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 23: Middle East & Africa Nephropathic Cystinosis Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027
Table 24: Middle East & Africa Nephropathic Cystinosis Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017–2027
Table 25: Middle East & Africa Nephropathic Cystinosis Treatment Market Value (US$ Mn) Forecast, by Sales Channel, 2017–2027